Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marsden

Showing results (271-280 of 1,476) with videos related to

Pageof 148
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to ratsS Rose, P Jenner, C D Marsden
British Journal of Pharmacology|July 1, 1979
5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pigD Chadwick, P Jenner, C D Marsden
Neuroscience Letters|June 4, 1985
The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmosetM Nomoto, P Jenner, C D Marsden
British Journal of Pharmacology|June 1, 1975
Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsP Jenner, C D Marsden, E Peringer
Neurology|October 1, 1990
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJ Rivest, N Quinn, C D Marsden
Pharmacology, Biochemistry, and Behavior|October 1, 1976
Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activityA Dolphin, P Jenner, C D Marsden
Biochemical Pharmacology|March 1, 1983
Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathwaysC Reavill, P Jenner, C D Marsden
Biochemical Pharmacology|June 15, 1983
Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigsG Luscombe, P Jenner, C D Marsden
Bulletin of the Pan American Health Organization|January 1, 1993
Chagas' disease: control and surveillance through use of insecticides and community participation in Mambaí, Goiás, BrazilM T García-Zapata, P D Marsden
Neuroscience Letters|November 11, 1988
The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmosetM Nomoto, P Jenner, C D Marsden
Pageof 148

Showing results (271-280 of 1,476) with videos related to

Sort By:
Pageof 148
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to ratsS Rose, P Jenner, C D Marsden
British Journal of Pharmacology|July 1, 1979
5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pigD Chadwick, P Jenner, C D Marsden
Neuroscience Letters|June 4, 1985
The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmosetM Nomoto, P Jenner, C D Marsden
British Journal of Pharmacology|June 1, 1975
Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsP Jenner, C D Marsden, E Peringer
Neurology|October 1, 1990
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJ Rivest, N Quinn, C D Marsden
Pharmacology, Biochemistry, and Behavior|October 1, 1976
Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activityA Dolphin, P Jenner, C D Marsden
Biochemical Pharmacology|March 1, 1983
Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathwaysC Reavill, P Jenner, C D Marsden
Biochemical Pharmacology|June 15, 1983
Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigsG Luscombe, P Jenner, C D Marsden
Bulletin of the Pan American Health Organization|January 1, 1993
Chagas' disease: control and surveillance through use of insecticides and community participation in Mambaí, Goiás, BrazilM T García-Zapata, P D Marsden
Neuroscience Letters|November 11, 1988
The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmosetM Nomoto, P Jenner, C D Marsden
Pageof 148